Display options
Cite
Lee GS, Park JC, Rhee JH, et al. Etiologic characteristics and index pregnancy outcomes of recurrent pregnancy losses in Korean women. Obstet Gynecol Sci. 2016;59(5):379-87doi: 10.5468/ogs.2016.59.5.379.
Lee, G. S., Park, J. C., Rhee, J. H., & Kim, J. I. (2016). Etiologic characteristics and index pregnancy outcomes of recurrent pregnancy losses in Korean women. Obstetrics & gynecology science, 59(5), 379-87. https://doi.org/10.5468/ogs.2016.59.5.379
Lee, Gi Su, et al. "Etiologic characteristics and index pregnancy outcomes of recurrent pregnancy losses in Korean women." Obstetrics & gynecology science vol. 59,5 (2016): 379-87. doi: https://doi.org/10.5468/ogs.2016.59.5.379
Lee GS, Park JC, Rhee JH, Kim JI. Etiologic characteristics and index pregnancy outcomes of recurrent pregnancy losses in Korean women. Obstet Gynecol Sci. 2016 Sep;59(5):379-87. doi: 10.5468/ogs.2016.59.5.379. Epub 2016 Sep 13. PMID: 27668201; PMCID: PMC5028645.
Copy Download .nbib Format: NLM
Share it on

Obstet Gynecol Sci. 2016 Sep;59(5):379-87. doi: 10.5468/ogs.2016.59.5.379. Epub 2016 Sep 13.

Etiologic characteristics and index pregnancy outcomes of recurrent pregnancy losses in Korean women.

Obstetrics & gynecology science

Gi Su Lee, Joon Cheol Park, Jeong Ho Rhee, Jong In Kim

Affiliations

  1. Department of Obstetrics and Gynecology, Keimyung University School of Medicine, Daegu, Korea.

PMID: 27668201 PMCID: PMC5028645 DOI: 10.5468/ogs.2016.59.5.379

Abstract

OBJECTIVE: The goal of this study was to evaluate the etiologies and clinical outcomes of Korean recurrent pregnancy loss (RPL) patients. And also, we investigated the differences between primary and secondary RPL patients, between two and three or more pregnancy losses.

METHODS: One hundred seventy eight women diagnosed as RPL were enrolled. We performed chromosomal analysis, thyroid stimulating hormone, prolactin, blood glucose, plasminogen activator inhibitor-1, natural killer cell proportion, anticardiolipin antibodies, antiphospholipid antibodies, lupus anticoagulant, anti-β2glycoprotein-1 antibodies, antinuclear antibody, protein C, protein S, antithrombin III, homocysteine, MTFHR gene, factor V Leiden mutation, and hysterosalphingography/hysteroscopic evaluation.

RESULTS: The mean age was 34.03±4.30 years, and mean number of miscarriages was 2.69±1.11 (range, 2 to 11). Anatomical cause (13.5%), chromosomal abnormalities (5.6%), and endocrine disorders (34.3%) were observed in RPL women. Elevated natural killer cell and antiphospholipid antibodies were observed in 43.3% and 7.3% each. Among of 178 women, 77 women were pregnant. After management of those women, live birth rate was 84.4% and mean gestational weeks was 37.63±5.12. Women with three or more RPL compared with women with two RPL had more common anatomical cause such as intrauterine adhesions and lower rates of spontaneous pregnancy. Compare with secondary RPL women, immunological abnormalities were more common in primary RPL. However, miscarriage rates were not different.

CONCLUSION: Immunological factor including autoimmune and alloimmune disorders was most common etiology of RPL. Inherited thrombophilia showed different patterns with other ethnic countries. Miscarriage rates were not different between primary and secondary RPL, or between two and three or more miscarriages group.

Keywords: Clinical outcomes; Etiology; Recurrent pregnancy loss

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

  1. Obstet Gynecol Sci. 2014 May;57(3):208-15 - PubMed
  2. Hum Reprod Update. 2013 Nov-Dec;19(6):656-73 - PubMed
  3. Arch Gynecol Obstet. 2015 Mar;291(3):671-9 - PubMed
  4. Fertil Steril. 1996 Oct;66(4):540-6 - PubMed
  5. Best Pract Res Clin Obstet Gynaecol. 2005 Feb;19(1):85-101 - PubMed
  6. Cochrane Database Syst Rev. 2014 Oct 21;(10):CD000112 - PubMed
  7. Fertil Steril. 1998 Aug;70(2):246-52 - PubMed
  8. Thromb Res. 2015 Feb;135(2):339-46 - PubMed
  9. Fertil Steril. 2013 Jan;99(1):63 - PubMed
  10. J Perinat Med. 2012 Feb 16;40(4):365-71 - PubMed
  11. Cochrane Database Syst Rev. 2013 May 31;(5):CD007752 - PubMed
  12. Am J Reprod Immunol. 2016 Jan;75(1):59-68 - PubMed
  13. Obstet Gynecol Clin North Am. 2014 Mar;41(1):133-44 - PubMed
  14. Obstet Gynecol Clin North Am. 2014 Mar;41(1):113-32 - PubMed
  15. Fertil Steril. 2005 Apr;83(4):821-39 - PubMed
  16. Am J Reprod Immunol. 2013 Jun;69(6):596-607 - PubMed
  17. Blood Cells Mol Dis. 2015 Oct;55(3):200-5 - PubMed
  18. Obstet Gynecol. 2012 Jan;119(1):37-43 - PubMed
  19. J Perinat Med. 2012 Feb 29;40(4):389-96 - PubMed
  20. Obstet Gynecol Clin North Am. 2014 Mar;41(1):103-12 - PubMed
  21. Am J Reprod Immunol. 2015 Apr;73(4):292-300 - PubMed
  22. J Thromb Haemost. 2006 Feb;4(2):295-306 - PubMed
  23. Thromb Res. 2006;117(6):653-8 - PubMed
  24. Br J Haematol. 2012 Jun;157(5):529-42 - PubMed
  25. Rev Obstet Gynecol. 2009 Spring;2(2):76-83 - PubMed
  26. Am J Reprod Immunol. 1996 Apr;35(4):363-9 - PubMed
  27. Iran Red Crescent Med J. 2014 Jul;16(7):e16763 - PubMed
  28. Fertil Steril. 2015 Sep;104(3):545-53 - PubMed
  29. Clin Obstet Gynecol. 2007 Mar;50(1):132-45 - PubMed
  30. Obstet Gynecol Clin North Am. 2014 Mar;41(1):145-55 - PubMed
  31. Fertil Steril. 2010 Mar 1;93(4):1234-43 - PubMed

Publication Types